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Abstract. Using fiducial markers on patient’s body surface to predict the tumor
location is a widely used approach in lung cancer radiotherapy. The purpose of this
work is to propose an algorithm that automatically identifies a sparse set of locations
on the patient’s surface with the optimal prediction power for the tumor motion. In
our algorithm, it is assumed that there is a linear relationship between the surface
marker motion and the tumor motion. The sparse selection of markers on the external
surface and the linear relationship between the marker motion and the internal tumor
motion are represented by a prediction matrix. Such a matrix is determined by solving
an optimization problem, where the objective function contains a sparsity term that
penalizes the number of markers chosen on the patient’s surface. Bregman iteration is
used to solve the proposed optimization problem. The performance of our algorithm
has been tested on realistic clinical data of four lung cancer patients. Thoracic 4DCT
scans with 10 phases are used for the study. On a reference phase, a grid of points
are casted on the patient’s surface (except for patient’s back) and propagated to other
phases via deformable image registration of the corresponding CT images. Tumor
locations at each phase are also manually delineated. We use 9 out of 10 phases of the
4DCT images to identify a small group of surface markers that are most correlated with
the motion of the tumor, and find the prediction matrix at the same time. The 10th
phase is then used to test the accuracy of the prediction. It is found that on average
6 to 7 surface markers are necessary to predict tumor locations with a 3D error of
about 1mm. It is also found that the selected marker locations lie closely in those
areas where surface point motion has a large amplitude and a high correlation with
the tumor motion. Our method can automatically select sparse locations on patient’s
external surface and estimate a correlation matrix based on 4DCT, so that the selected
surface locations can be used to place fiducial markers to optimally predict internal
tumor motions.
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1. Introduction
Modern radiotherapy techniques, such as Intensity Modulated Radiation Therapy
(IMRT), are capable of delivering highly conformal radiation dose to a cancerous target
while sparing critical structures and normal tissues. Intra-fraction tumor motion caused
by patient respiration, however, may lead to geometric miss of the target and hence5
potentially compromise the efficacy of these techniques while treating tumors at lung
or upper abdomen area. To mitigate this problem, a number of techniques have been
developed, such as gated treatment, for which accurate modeling and prompt prediction
of tumor motion are necessary (Jiang, 2006b; Jiang, 2006a).
Tumor localization methods can be generally categorized according to the locations10
of surrogates. Methods using internal surrogates, such as gold markers implanted in
or near tumor, are accurate but have issues like the risks of pneumothorax for lung
cancer patients (Arslan et al., 2002; Geraghty et al., 2003), marker migration (Nelson
et al., 2007), and the extra imaging radiation dose (Jiang, 2006b). In contrast, external
surrogate based tumor localization is usually noninvasive and radiation free. In such15
methods, a regression model is first built between the coordinates of some empirically
selected external surrogates and those of the tumor using a training data set. Such a
model will be utilized to predict the tumor location using the real-time measurements of
the marker locations during a treatment via, for example, Cyberknife Synchrony system
(Accuray Corporate, Sunnyvale, CA, USA) (Pepin et al., 2011). Yet, the accuracy of this20
method usually relies on the correlation between external marker motion and internal
tumor motion for a particular patient (Hoisak et al., 2004).
In fact, there are a few questions one should keep in mind while using external
markers for tumor tracking. First of all, how many external markers are necessary?
While using more markers may potentially provide more comprehensive information for25
tumor location estimation, it is evident that the motion of points on a patient surface is
strongly correlated and information from many surface markers is likely to be redundant.
Clinically, it is necessary and desirable to use a minimum number of markers to predict
the tumor motion to a satisfactory degree. Second, given the number of markers, where
shall we optimally place them? Despite a lot of studies regarding the patient breathing30
pattern and the selection of marker locations(Yan et al., 2006; Wu et al., 2008), markers
are placed empirically in most clinical practice.
In this study, we will attempt to answer the aforementioned two questions utilizing
a sparse optimization approach. Specifically, our objective is to choose a sparse set of
points from all the points on the front surface of a patient, so that a linear motion model35
yields the smallest error in tumor location prediction. With a novel optimization model
to formulate this objective in a clean and precise mathematical language, as well as
an effective numerical algorithm to solve the problem, we can effectively yet efficiently
identify the key surface points used to predict tumor motion. A linear regression model is
also developed during the optimization process, such that those markers collaboratively40
predict tumor locations to a satisfactory extent.
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2. Methods and Materials
We start with an introduction of some notations. Denote Y ∈ R3×m as a 3 × m
matrix whose column vectors are the three Cartesian coordinates of the center of
the tumor at various times tj with j = 1, 2, . . . ,m. Suppose there are k candidate45
surface points available for tumor motion prediction. We denote the coordinates of
the collection of all of those surface points at a given time tj as a column vector
Xj = [~x1(tj), ~x2(tj), . . . , ~xk(tj)]
T , where each vector ~xi = [~xi1, ~xi2, ~xi3] for i = 1, ..., k
contains three entries corresponding to the three Cartesian coordinates of the point i.
If we assemble all the collections of markers Xj associated with different time tj, we will50
have the following matrix X := [X1, X2, · · · , Xm] ∈ R3k×m.
2.1. Optimization Model
Assume, for simplicity, there is a linear motion model that relates the external marker
motion and the tumor motion. Mathematically speaking, there exist a matrix A ∈ R3×3k
such that AX ∼ Y . Note that the columns of the matrix A can be also associated to55
those k surface points, each with three coordinates. If one column of the matrix A is
non-zero, the corresponding coordinate for that surface point is then utilized to predict
the tumor motion. As it is our purpose to select only a few surface points for tumor
motion prediction, the problem can be casted as finding a matrix A with only a few
non-vanishing columns, such that the motion of tumor recorded in Y can be accurately60
characterized by AX. Although this is simply a linear motion prediction model, our
numerical experiments indicate that such an assumption is reasonable and leads to
accurate tumor location estimations. We shall refer to the problem of optimal marker
selection as the problem of finding the linear dependence of the motion of the internal
tumor with the motion of some sparsely selected markers.65
We propose our optimal marker selection model as follows:
min
A
{‖A‖2,1 : AX = Y } , (1)
where ‖A‖2,1 :=
∑
j
(∑
i a
2
i,j
) 1
2 and A = (ai,j). In this optimization problem, the
objective function is defined in such a way that it groups all the matrix elements
in a column of A utilizing an `2-norm and then takes `1-norm among all columns.70
Minimizing such an objective function term enables us to enforce sparsity at only the
level of matrix columns. This idea is inspired by that of compressed sensing (Candes
et al., 2006; Candes and Tao, 2006; Candes and Tao, 2005; Donoho, 2006), which is a
recent revolutionary concept in information theory. The applications of such a `2,1 norm
has been recently explored in many problems, such as beam orientation optimization75
for IMRT(Jia et al., 2011), to effectively select only a few groups of elements. Similar
idea was also used in (Esser et al., 2011) where the `1,∞ norm was used for matrix
factorization with applications in hyperspectral image unmixing. We remark that the
model (1) not only sparsely selects markers needed to track the motion of an internal
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tumor, but also provides the linear dependence of the motion of the selected markers80
with that of the tumor at the same time. All such information is integrated within the
solution matrix A.
2.2. Fast Numerical Algorithm
To solve the proposed optimization problem (1), we use a Bregman distance-based
algorithm proposed by Yin et. al. (Yin et al., 2008), which is proven to be efficient for85
`1 minimization problems. Given matrices X and Y , the fast algorithm that solves (1)
can be written into an iterative form as:
Ak+1 = arg min
A
{
µ‖A‖2,1 + 12‖AX − Y k‖2F
}
,
Y k+1 = Y k + Y − Ak+1X, (2)
where k is the iteration index and ‖ · ‖F is the Frobenius norm. The optimization
problem in the first subproblem of (2) can be solved using the proximal forward-90
backward splitting algorithm (Combettes and Wajs, 2006; Hale et al., 2007), which
by itself is an iterative algorithm as:
Ap+1 = Tµ(Ap − δ(ApX − Y k)XT ), (3)
where p is the iteration index in this subproblem and Tµ(B), for a given matrix
B = [B1, B2, . . . , Bm], is defined as
Tµ(B) :=
[
max(|B1| − µ, 0) B1|B1| , · · · ,max(|Bm| − µ, 0)
Bm
|Bm|
]
.
We note that (Donoho, 1995; Wang et al., 2007) Tµ(B) is the closed form solution
to min
X
{
µ‖X‖2,1 + 12‖X −B‖2F
}
. For computation efficiency, we shall not solve the95
subproblem (2) accurately by using numerous iterations of (3), but only use one iteration
instead. Now, applying (3) (with only one iteration) to (2), we have the following fast
algorithm that solves (1) (also known as the Bregmanized operator splitting algorithm
(Zhang et al., 2010)):
Algorithm 1 Optimal Marker Selection Algorithm
Step 0. Initialization: k = 0, A0 = 0 and Y 0 = 0.
while stopping criteria is not satisfied do
Step 1.
Ak+1 = Tµ(Ak − δ(ApX − Y k)XT )
Step 2.
Y k+1 = Y k + Y − Ak+1X
end while
The proof of the mathematical properties of this algorithm, such as convergence,100
is beyond the scope of this paper. Interested readers can consult references for more
details(Yin et al., 2008; Zhang et al., 2010).
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For realistic patient data, because of the presence of noise and the fact that the
motion of internal tumor is only approximately linearly dependent on the external
markers, we should not expect the relative residual ‖AkX−Y ‖F/‖Y ‖F decrease to 0. In
fact, numerically we observe that the relative residual should have a lower bound whose
value depends on X and Y and it is very difficult to estimate beforehand. Therefore,
we adopt the following stopping criteria:
‖AkX − Y ‖F
‖Y ‖F < 1 or
‖Ak−1 − Ak‖F
‖Ak‖F < 2.
In other words, we fix an 1 as a satisfactory amount for the residual; meanwhile, if such
residual is not attainable, we will terminate the algorithm when Ak is not changing too
much according to the tolerance 2.105
2.3. Patient Data
To validate our algorithm with realistic clinical cases, 4DCT scan data of four lung
cancer patients is used. For those patients, a four-slice GE LightSpeed CT scanner
(GE Medical Systems, Milwaukee, WI, USA) was used to acquire the 4DCT data for
treatment simulation. Each axial CT slice has a thickness of 2.5mm and the 4DCT110
was obtained using respiratory signals from the Varian RPM system (Varian Medical
Systems, Inc., Palo Alto, CA, USA). The 4DCT scan consists of ten different phases
of one breathing cycle; and the CT volume at each respiratory phase consists of 100 to
144 slices of CT images covering the most of thorax area depending on patients. Each
slice of CT image has 512× 512 pixels, with a pixel size of 0.977× 0.977mm2. For each115
patient, tumor GTV was manually contoured on 4DCT scan images of ten respiratory
phases by an expert observer and the 3D tumor center coordinates were identified.
Table 1 summarizes the number of CT image slices for each CT image volume and
the average tumor motion amplitude in the superior-inferior(S-I) direction and average
surface motion amplitude for each patient. It can be observed that the average tumor120
motion amplitude in the S-I direction range from 3.3mm to 9.0mm. The average surface
point motion amplitude ranges among all the patients are found to be 0.8mm to 2.0mm.
Patient No. of slices Tumor motion ampli-
tude in S-I (mm)
Average surface mo-
tion amplitude (mm)
1 144 6.3 2.0
2 100 9.0 1.5
3 132 7.4 1.8
4 104 3.3 0.8
Table 1. Summary of patient data with number of CT slices, average tumor motion
amplitude in S-I direction, and average surface motion amplitude for each patient.
Meanwhile, the external surfaces of each patient, excluding the patient’s back, at
each phase are extracted by segmenting the CT images using a simple threshold method.
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For each patient, the CT image volume at the end of inhale is set as the target image;125
the other nine CT image volumes, corresponding to the other nine different respiratory
phases, are set as moving images. The correspondence between surfaces at different
phases is established by deformable image registration (Thirion, 1998; Gu et al., 2010).
When surface points are available on the external surfaces of each patient, we further
sub-sampled the point sets uniformly to reduce the total number of candidate points130
for a better computational efficiency. In our experiments, we choose approximately 200
candidate surface points for each patient.
2.4. Validation
To validate our marker selection algorithm, we employ an leave-one-out cross validation
(LOOCV) method. Specifically, 10 tests are performed for a patient, and for each test,135
we single out one of the 10 respiratory phases and use the other 9 to form the matrix Y
and solve for the matrix A using Algorithm 1. We then validate our method by using
the matrix A to predict the location of the tumor at the phase that has been singled
out. The deviation of the predicted tumor location from the actual tumor location is
characterized by the 3D Euclidean distance between them in mm.140
The patients’ 4DCT image volumes cover a complete breathing cycle, hence contain
information of external surface motion. We could in principle identify regions of interest
(ROIs) on the patient surface that strongly correlate with tumor motions. It is expected
that the marker locations selected by Algorithm 1 should fall closely into those ROIs.
This also serves as a criterion for the justification of the correctness of our marker145
selection algorithm. To select the ROI, we consider the following two metrics. First,
from the deformation vector fields between different respiratory phases, the motion
trajectory for all surface points were extracted. The correlation function between the
internal tumor motion in the S-I direction and the motion vector of each point on the
external surface was employed as a metric. However, only part of the external surface150
has considerable motion amplitude and those points with small motion amplitude should
not be considered for predicting tumor motions despite their possible high correlations
with tumor S-I motion. Therefore, we only focus on the surface region with large
motion amplitudes. Combining the two criteria, we define the ROI as the areas on the
surface in which the motion amplitude is larger than 80% of the maximum value and155
the correlation is above 0.85. Although those threshold values for the two criteria are
chosen empirically, the general conclusions presented in the rest of this paper are found
not sensitive to them.
3. Results
3.1. Marker selection160
We have studied the validation of our surface marker selection algorithm on 4 lung
cancer patients. The selected 6 surface markers in one typical patient (patient No. 4)
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Figure 1. Left: Markers selected by our algorithm are shown as red circles on one of
the patient’s surface. Right : the LOOCV results for the same patient using the phases
1 through 9 as training data (blue dots) and the phase 10 as the testing data (red dot).
The red circle is the predicted tumor location.
are drawn in 3D space on the patient surface, as shown in the left panel of Fig. 1.
Meanwhile, in the right panel of Fig. 1, we demonstrate the LOOCV results for the
same patient using the phases 1 through 9 as training data and the phase 10 as the165
testing data. Specifically, the blue dots are the locations of the tumor in the training
phases and the red dot is the location of the tumor at the phase 10. The red circle is the
predicted location using the selected surface markers and the matrix A. The 3D distance
between the true tumor location and the predicted location is 0.83mm, indicating the
great capability for tumor motion prediction of our algorithm.170
Error (mm) #Markers Time (sec)
Patient mean std mean std mean std
1 1.85 1.15 5.5 0.85 10.6 4.5
2 1.22 1.06 5.5 1.58 4.6 1.9
3 0.44 0.28 5.4 1.84 10.8 3.0
4 0.83 0.29 7.5 1.35 30.5 11.6
Average 1.08 0.69 5.98 1.04 14.1 5.2
Table 2. Summary of tumor location prediction errors, the numbers of markers
selected, and the computation time.
A summary of the results of all 10 tests for each of the 4 patients is given in Table 2.
For each patient, we compute the mean and the standard deviation of the 3D errors for
the predicted tumor locations and the number of selected markers over all the 10 tests
in the LOOCV. It is found that, on average, our algorithm can automatically select
about 6 surface markers that collaboratively predict tumor motion with an 3D error175
about 1mm.
Algorithm 1 is implemented using MATLAB on a laptop with Intel Core i7 (1.73
GHz) CPU and 8.0G RAM. As for the computation time, it is found that the average
time required to perform one optimization is about 14sec. We emphasize that the
time reported here is the one for marker selection. Once the markers are selected, the180
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matrix A becomes available. The prediction of tumor motion using selected markers
only requires a simple matrix multiplication and hence the prediction can be achieved
in a negligible amount of computation time. From Table 2, it is also found that the
computational time for marker selection varies from case to case, which is possibly
ascribed to the different patient sizes.185
3.2. Comparison with ROI
The correlation between the internal tumor motion in the S-I direction and the external
surface motion is shown on Fig. 2. In Fig. 3, we also present the amplitude of external
surface motion. Combining the correlation map and the motion amplitude map, the
ROIs for each patient can be identified, shown as red regions in Fig. 4, where the ROIs190
have correlation coefficients larger than 0.85 and surface motion amplitude greater than
80% of the maximum value. Apparently, the ROIs are highly dependent on different
breathing motion patterns among patients. We also plot in Fig. 4 the locations of
markers selected with our algorithm. We can see that most of the marker positions
selected by our algorithm fall inside or close to the ROIs, which indicate the robustness195
of our algorithm.
Figure 2. Color maps showing the correlation coefficients between the external surface
motion and the internal tumor motion for 4 patients.
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Figure 3. Color maps showing the amplitude of external surface motion for 4 patients.
Figure 4. Color maps showing the regions of interest (where the motion amplitudes
are relatively large and the correlation coefficients are relatively high) and the locations
of the selected markers.
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4. Conclusions
In this paper, we proposed a novel mathematical model to automatically determine the
optimal number and locations of fiducial markers on patient’s surface for predicting
lung tumor motion. We also introduced an efficient numerical algorithm for solving200
the proposed model. Experiments on the 4DCT data of 4 lung cancer patients have
shown that, by using our method, usually 6-7 markers are selected on patient’s external
surface. Most of these markers are in the regions where the surface motion is relatively
large and the correction between the surface motion and the internal tumor motion is
relatively high. Using these markers, the lung tumor positions can be predicted with an205
average 3D error of approximately 1mm. Both the number of markers and the prediction
accuracy are clinically acceptable, indicating that our method can be used in clinical
practice.
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